| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Revenue | $18.8B Q3 2025 | $20.9B Q4 2025 | +11% sequential, flat YoY |
| Adjusted EPS | $0.92 Q3 2025 | $0.87 Q4 2025 | -5 cents sequential slide |
| Total Segment OP | $845M Q3 2025 | $821M Q4 2025 | -3% sequential decline |
| AS&O Segment OP | $379M Q3 2025 | $444M Q4 2025 | +17% sequential recovery |
| Crushing OP | $13M Q3 2025 | $66M Q4 2025 | +408% but still down 69% YoY |
| Carb Solutions OP | $336M Q3 2025 | $299M Q4 2025 | -11% sequential drop |
| Nutrition Segment Revenue | $1.9B Q3 2025 | $1.8B Q4 2025 | -5% sequential decline |
| Nutrition Segment OP | $130M Q3 2025 | $178M Q4 2025 | +37% sequential surge |
| Cash from Operations Before WC | $2.1B YTD Q3 2025 | $2.7B Full Year 2025 | Strong full-year delivery |
| Inventory Reduction Benefit | $3.2B YTD Q3 2025 | $1.5B Q4 2025 | Massive working capital extraction |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.